company background image
ABT logo

Abbott Laboratories BASE:ABT Stock Report

Last Price

AR$32.60k

Market Cap

AR$203.9t

7D

-4.0%

1Y

44.9%

Updated

19 Nov, 2024

Data

Company Financials +

ABT Stock Overview

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. More details

ABT fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance5/6
Financial Health6/6
Dividends5/6

Rewards

Risk Analysis

No risks detected for ABT from our risk checks.

Abbott Laboratories Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Abbott Laboratories
Historical stock prices
Current Share PriceUS$32,600.00
52 Week HighUS$38,190.50
52 Week LowUS$20,037.50
Beta0.72
11 Month Change-8.68%
3 Month Change-9.26%
1 Year Change44.89%
33 Year Change386.17%
5 Year Change1,954.19%
Change since IPO308,904.74%

Recent News & Updates

Recent updates

Shareholder Returns

ABTAR Medical EquipmentAR Market
7D-4.0%0%0%
1Y44.9%0%0%

Return vs Industry: ABT exceeded the AR Medical Equipment industry which returned 16% over the past year.

Return vs Market: ABT underperformed the AR Market which returned 198.8% over the past year.

Price Volatility

Is ABT's price volatile compared to industry and market?
ABT volatility
ABT Average Weekly Movement3.3%
Medical Equipment Industry Average Movement0%
Market Average Movement0%
10% most volatile stocks in AR Market0%
10% least volatile stocks in AR Market0%

Stable Share Price: ABT has not had significant price volatility in the past 3 months compared to the AR market.

Volatility Over Time: ABT's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1888114,000Robert Fordwww.abbott.com

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

Abbott Laboratories Fundamentals Summary

How do Abbott Laboratories's earnings and revenue compare to its market cap?
ABT fundamental statistics
Market capAR$203.92t
Earnings (TTM)AR$5.75t
Revenue (TTM)AR$41.29t

35.4x

P/E Ratio

4.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ABT income statement (TTM)
RevenueUS$41.22b
Cost of RevenueUS$18.17b
Gross ProfitUS$23.04b
Other ExpensesUS$17.30b
EarningsUS$5.74b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)3.31
Gross Margin55.91%
Net Profit Margin13.94%
Debt/Equity Ratio37.6%

How did ABT perform over the long term?

See historical performance and comparison

Dividends

1.9%

Current Dividend Yield

67%

Payout Ratio